share_log

益佰制药(600594.SH):暂无针对猴逗感染药物的研发计划

Guizhou Yibai Pharmaceutical (600594.SH): There is currently no research and development plan for drugs against Monkey Pox infection.

Gelonghui Finance ·  Sep 6 07:33

Guizhou Yibai Pharmaceutical (600594.SH) stated on the interactive platform on September 6th that the company currently has no plans to develop drugs for monkey teasing infections.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment